Novel CTLA4/CD28 ligands and uses therefor

Details for Australian Patent Application No. 2004200586 (hide)

Owner Dana-Farber Cancer Institute, Inc. Genetics Institute, LLC.

Inventors Nadler, Lee M.; Freeman, Gordon J.

Agent FB Rice

Pub. Number AU-B-2004200586

Parent 53395

Filing date 13 February 2004

Wipo publication date 11 March 2004

Acceptance publication date 20 September 2007

International Classifications

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 17/14 (2006.01) Carrier-bound or immobilised peptides

C07K 19/00 (2006.01) Hybrid peptides

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

G01N 33/545 (2006.01) Investigating or analysing materials by specific methods not covered by groups

Event Publications

26 February 2004 Complete Application Filed

4 March 2004 Corrigenda

  Complete Applications Filed - Name Index Under the names Dana-Farber Cancer Institute and Repligen Corporation, Application No. 2004200586, Under INID (54) correct the title to read Novel CTLA4/CD28 ligands and uses therefor.

11 March 2004 Application Open to Public Inspection

  Published as AU-B-2004200586

22 July 2004 Amendment Made

  The nature of the amendment is: Amend the name of the applicant from Dana-Farber Cancer Institute and Repligen Corporation to Dana-Farber Cancer Institute, Inc. and Genetics Institute, LLC.

20 September 2007 Application Accepted

  Published as AU-B-2004200586

11 October 2007 Corrigenda

  Applications OPI - Name Index Under the name Dana-Farber Cancer Institute, Inc., application No. 2004200586, under INID (31), correct the priority details to read This Application is a Divisional of 772061 filed 7/12/00

13 March 2008 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 20 Sep 2007. Address for service in Australia - FB Rice & Co Level 23 200 Queen Street Melbourne VIC 3000 2005

20 March 2008 Standard Patent Sealed

17 July 2008 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 20 Sep 2007

24 February 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004200587-An air conditioner register and diffuser therefor

2004200585-Folded guide link stirling engine